Regulatory & Legal

After a chaotic 2025, businesses face a new normal of complex digital taxes and aggressive enforcement, with only minor glimmers of relief in 2026.

As Sera Prognostics preps its year-end report, investors watch to see if its groundbreaking preterm birth test can deliver financial health.

Data shows Achieve Life Sciences' drug helps smokers quit, even after multiple failed attempts with other drugs, as a critical FDA decision looms.

A new analysis reveals major banks lend to California's Latino homebuyers at less than half the rate of nonbanks, threatening economic mobility.

After solving a key manufacturing flaw, CervoMed advances its promising dementia drug, neflamapimod, to a Phase 3 trial with an optimized dose.

VC firm Halogen Ventures injects capital into nine Alabama startups, betting on female entrepreneurs to transform the state's burgeoning tech ecosystem.

FDA approves Glenmark's generic inhaler with 180-day exclusivity, promising lower costs for millions and disrupting a major respiratory drug market.

A landmark draft permit advances a first-of-its-kind project in Louisiana, promising carbon-negative power, SAF, and a major economic boost for the region.

A new partnership integrates advanced AI for brain lesion tracking into a global imaging network, promising safer Alzheimer's treatments and faster diagnostics.

UCLA forecast predicts 3% GDP growth driven by massive AI spending and tax cuts, but California's job market paradox reveals a widening economic divide.

Theolytics secures a prestigious €8 million EU grant to advance its unique cancer-killing virus, offering new hope for hard-to-treat ovarian cancer.

A new UK facility, backed by government funds, will be the only one of its kind, aiming to accelerate drug development and boost domestic life sciences.

The VCT posts flat returns but rewards investors with a special dividend, announcing a new chair as it navigates a shifting regulatory landscape.

Singapore fintech EFGH taps media pioneer Woon Tai Ho for its board, bolstering governance as it pursues a $425M U.S. listing via a SPAC merger.

Recycling giant Cabka grapples with a major cybersecurity breach, testing its operations, supply chain, and the digital defenses of the green economy.

With four new partners and a zero-markup model, Harrison.ai's Open Platform aims to democratize access to powerful medical AI tools for providers globally.

Immunome announces stellar Phase 3 data for its desmoid tumor drug, varegacestat, and details a robust, well-funded ADC pipeline aimed at solid tumors.

The nation's leading aesthetic provider launches a Salmon DNA Facial, XTherma, and NAD+ injections, betting on the science of regenerative beauty.

The combination of Banijay Entertainment and All3Media forges a new media giant, reshaping the global production landscape with unparalleled scale and IP.

The Dutch semiconductor giant posts record 2025 revenue, fueled by AI-driven demand for advanced chips, and signals confidence with a strong 2026 outlook.